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Abstract The 42 kDa precursor of surfactant protein B
generates the 79 residue mature SP-B polypeptide, which belongs
to the family of saposin-like proteins and has unique functional
roles in pulmonary surfactant. From sequence comparisons it has
been suggested that proSP-B, in addition to SP-B, contains two
saposin-like domains, but their existence has until now not been
experimentally verified. The 381 residue human proSP-B was
now fused to an N-terminal poly-His tag, expressed in
Escherichia coli, and purified from inclusion bodies by resolubi-
lisation with 2.5% (w/v) SDS and, after removal of SDS,
subsequent metal affinity chromatography. Recombinant proSP-
B thus obtained exhibits about 35% K-helical structure in sodium
phosphate buffer and is proteolytically cleaved preferentially
between the three saposin-like domains. These results experi-
mentally support that proSP contains, in addition to SP-B, two
further saposin-like domains.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Lung surfactant is a complex mixture of phospholipids and
proteins. The main function of this system is to reduce the
surface tension at the alveolar air/liquid interface. Four di¡er-
ent surfactant-associated proteins have been puri¢ed. The
larger surfactant proteins A (SP-A) and D (SP-D) are hydro-
philic, while surfactant protein B (SP-B) and C (SP-C) are
small and insoluble in water, see [1]. SP-B and SP-C probably
have unique functional roles in the formation of a surface
tension-reducing lipid monolayer at the alveolar air/liquid in-
terface. These two hydrophobic proteins are unrelated in
structure, but both the two mature proteins are formed by
proteolytic cleavage from larger precursors. SP-B, with an
Mr of 17 400 (unreduced) and 8700 (reduced), emanates
from a 42 000 Da precursor [2,3], while SP-C with an Mr of
4200 is produced from a 22 000 Da precursor [4,5]. The cDNA
coding for the precursor of human SP-B (proSP-B) has been
cloned and sequenced and codes for a protein of 381 amino
acid residues [3]. The mature SP-B polypeptide chain consists
of 79 residues, forms disulphide-dependent homodimers, and
displays about 45% K-helical secondary structure [6,7]. Each
SP-B monomer contains three intramolecular disulphide
bridges that link Cys-8^Cys-77, Cys-11^Cys-71 and Cys-35^
Cys-46 [6].
From sequence alignments with saposins (which promote
enzymatic degradation of sphingolipids in lysosomes),
proSP-B has been proposed to contain three tandem repeats
of about 90 residues [8], where mature SP-B corresponds to
the second of these repeats (residues 201^279 in proSP-B). In
these three so-called saposin-like repeats 17 positions are con-
served, including the six half-cystine residues involved in in-
tramolecular disulphide bonds. Furthermore, SP-B, amoeba-
pores (which are pore-forming polypeptides from Entamoeba
histolytica), parts of acid sphingomyelinase and acyloxyacyl-
hydrolase, the saposins and NK-lysin (which is an antibacte-
rial and tumourolytic polypeptide from Natural Killer cells),
exhibit 17^24% pairwise residue identities [9]. Moreover, the
intramolecular disulphide patterns in SP-B, NK-lysin, and
saposins B and C are identical [6,10,11]. From the similarities
between SP-B and the other members of the saposin-like fam-
ily, it has been suggested that they exhibit a four-helix top-
ology [9], and molecular modelling of NK-lysin and amoeba-
pore has likewise yielded a four-helix structure [12].
We have expressed human proSP-B in E. coli, and charac-
terised the recombinant protein in terms of overall secondary
structure and susceptibility to limited proteolysis with trypsin.
This shows that proSP-B exhibits about 35% K-helical struc-
ture and is preferentially cleaved between the three proposed
saposin-like domains.
2. Materials and methods
2.1. Preparation of human proSP-B cDNA and construction of the
expression vector
Polymerase chain reaction (PCR) primers were synthesised based
on the human proSP-B cDNA sequence [3]; 5P-ATA CAT ATG GCT
GAG TCA CAC CTG CTG-3P and 5P-ATA GGA TCC TCA AAG
GTC GGG GCT GTG GAT AC-3P, which correspond to nucleotides
1^21 and 1136^1162 of human proSP-B, and contain an NdeI and
BamHI cleavage site, respectively. PCR was carried out with a Robo-
Cycler (Stratagene) for 30 cycles consisting of denaturation at 95‡C
for 2 min, annealing at 51‡C for 2 min and extension at 72‡C for
2 min. Reaction mixtures (total volume 100 Wl) contained reaction
bu¡er (New England Bio Labs), 10 WM of each primer, 2 mM dNTPs,
1 unit of Vent polymerase (New England Bio Labs) and 1 ng of adult
human lung cDNA (Clontech). The resulting product was inserted
into the pCRII vector by use of the TA Cloning kit (Invitrogen),
and sequenced by the dideoxy chain-termination method [13] using
the Sequenase kit (United States Biochemicals). The pCRII insert was
liberated by NdeI and BamHI cleavage and religated into the pET15b
vector (Novagen), which gives an N-terminal poly-His tag fused to the
recombinant protein. The ligation product was transferred into E. coli
JM 109 cells for selection of plasmid-carrying clones. Finally, pET15b
vector with inserted proSP-B DNA was transferred to E. coli BL21
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DE3 cells, which contain an integrated copy of the T7 DNA polymer-
ase gene under control of the lac UV5 promoter.
2.2. Expression and puri¢cation of recombinant proSP-B (rproSP-B)
A single colony of E. coli BL21 DE3 transformed with pET15b/
proSP-B vector was grown overnight at 37‡C in 25 ml LB medium
containing 50 Wg/ml ampicillin. A 15 ml aliquot of the culture was
inoculated into 500 ml of LB medium containing 50 Wg/ml ampicillin
and was grown to an OD600nm of 1.2^1.5. Induction was then per-
formed by addition of isopropyl-L-D-thiogalactopyranoside (IPTG) to
1 mM. The culture was grown for an additional 3 h at 37‡C, and
harvested by centrifugation at 5000 rpm for 15 min. The bacterial
pellet was suspended in 18 ml bu¡er A (20 mM Tris-HCl, 100 mM
NaCl, pH 8.0) and sonicated 10 times at 60 Hz for 30 s on ice with an
interval of 30 s. After centrifugation at 15 000 rpm for 15 min, the
supernatant (supernatant 1) was saved and the pellet was resuspended
in 15 ml bu¡er A containing 2.5% (w/v) SDS, sonicated as described
above, and incubated at 37‡C for 30 min. After another centrifugation
at 15 000 rpm for 15 min, the supernatant was divided into two ali-
quots, which were dialyzed at room temperature against 20 mM Tris-
HCl, pH 8.0, in the presence (supernatant 2) or absence (supernatant
3) of 2.5% (w/v) SDS, respectively. Supernatants 1^3 were separately
loaded onto a Talon Metal A⁄nity column (5 ml bed volume, Clon-
tech) pre-equilibrated with bu¡er A. The columns were washed with
20 bed volumes of bu¡er A, and 20 volumes of bu¡er A containing
5 mM imidazole. The bound proteins were ¢nally eluted with 3 bed
volumes of bu¡er A containing 100 mM imidazole. The eluates were
dialyzed at room temperature against 50 mM sodium phosphate buf-
fer, pH 6.0, or 20 mM Tris-HCl, pH 8.0, and stored at 8‡C.
2.3. Limited proteolysis
Limited trypsin digestion of rproSP-B in 20 mM Tris-HCl, pH 8.0
(1:500, w/w, protease to substrate ratio) was carried out at 37‡C for
24 h. After proteolysis, the product was lyophilised, dissolved in a
small volume of sample bu¡er (62 mM Tris-HCl, pH 6.8, 2.5%
SDS, 10% glycerin, 5% mercaptoethanol, 0.02% bromophenol blue),
and separated by SDS/PAGE in 15% gels. Protein bands were electro-
transferred from the gel to a PVDF membrane (Millipore) for amino
acid sequence analysis with an Applied Biosystems 470 A gas-phase
sequencer equipped with on-line HPLC for identi¢cation of released
phenylthiohydantoin derivatives.
2.4. Circular dichroism (CD) spectroscopy
Freshly prepared rproSP-B in 50 mM phosphate bu¡er at pH 8.0,
and the same sample after 4 months storage at 8‡C, were analysed.
Reduction was performed by incubation with 5 mM DTT for 5.5 h at
37‡C. CD spectra were recorded in a J-720 spectropolarimeter (Jasco)
at 22‡C. The scan speed was 20 nm/min (184^260 nm), the response
time 2 s, and the resolution 2 data points/nm. The spectra shown are
the averages of two scans. The concentration of rproSP-B was deter-
mined by amino acid analysis. a is in units of degUcm2Udmol31.
Content of K-helical secondary structure was estimated from the mo-
lar ellipticities at 208 and 222 nm [14].
2.5. Immunodetection
Recombinant proSP-B (0.3 Wg) before or after reduction (5 mM
DTT, 4 h at 37‡C) was spotted onto nitrocellulose membranes (Amer-
sham) and the membranes were blocked for 1 h with 5% milk powder
in phosphate-bu¡ered saline containing 2.5% Tween 20 (TPBS). The
membranes were then washed 3 times for 10 min in TPBS containing
0.25% Tween 20 and subsequently probed overnight at room temper-
ature with a monoclonal anti-human SP-B antibody (HS-2 [15], kindly
provided by Prof. Y. Suzuki, Kyoto, Japan). After further 3U10 min
washes in TPBS, anti-mouse IgG antibodies conjugated with alkaline
phosphatase were added. After washing, binding of the secondary
antibody was detected by the colour development after addition of
bromo-chloro-indolyl-phosphate (2 mg) and nitro-blue tetrasolium (4
mg) in 100 mM Tris-HCl, 100 mM NaCl, 5 mM MgCl2, pH 9.0.
3. Results
3.1. Expression of proSP-B in E. coli and puri¢cation of the
recombinant protein
A 1.2 kbp fragment was PCR-ampli¢ed from human lung
cDNA by the use of probes corresponding to the 5P and 3P
ends of proSP-B. 435 bp of the 5P end and 360 bp of the 3P
end of the PCR product were sequenced by the dideoxy chain-
termination method, and were found to be identical to the
corresponding regions reported for the proSP-B cDNA se-
quence (data not shown). The fragment was puri¢ed by agar-
ose electrophoresis and ligated into the expression vector
PET15b. The vector containing inserted DNA was transfected
into E. coli strain BL21 DE3, and rproSP-B was produced
after addition of IPTG.
No rproSP-B could be puri¢ed from the soluble fraction
after cell lysis (Fig. 1, lane 2). Instead recombinant proSP-B
was puri¢ed from the insoluble inclusion bodies that precipi-
tated after centrifugation of the lysed bacterial cells. Recombi-
nant proSP-B in such inclusion bodies can be puri¢ed to ap-
parent homogeneity after resolubilisation using 2.5% SDS.
Removal of SDS by dialysis after resolubilisation does not
cause detectable precipitation, and signi¢cantly increases the
yield of rproSP-B upon a⁄nity chromatography (Fig. 1, lanes
3 and 4). The identity of the puri¢ed protein was con¢rmed by
amino acid analysis and protein sequence determination. Pu-
ri¢ed rproSP-B was soluble in sodium phosphate bu¡er and
remained in solution at least for several months. The maximal
yield obtained was approximately 1.5 mg rproSP-B/l cell cul-
ture, as determined by amino acid analysis. Occasionally low-
er yield of recombinant protein (0.2^0.5 mg per l cell culture)
was obtained. Recombinant proSP-B analysed by SDS/PAGE
under reducing conditions gives an estimated molecular mass
of 43 kDa (Fig. 1), which is in agreement with the expected
mass of 44.4 kDa of the His-tag/proSP-B fusion protein.
3.2. Secondary and quaternary structure of rproSP-B
The overall secondary structure of rproSP-B was studied by
CD spectroscopy. Recombinant proSP-B in sodium phos-
phate bu¡er exhibits a far-UV CD spectrum indicative of a
protein with a signi¢cant content of secondary structure, and
which is similar to the spectrum of SP-B in dodecylphospho-
choline micelles (Fig. 2). The minima at 208 and 222 nm and
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Fig. 1. Puri¢cation of rproSP-B. Proteins eluted from the metal af-
¢nity column with 100 mM imidazole were analysed by SDS/PAGE
in a 15% acrylamide gel. Lane 1: molecular weight markers: phos-
phorylase b (94 kDa), bovine serum albumin (67 kDa), ovalbumin
(43 kDa), carbonic anhydrase (30 kDa), soybean trypsin inhibitor
(20 kDa) and K-lactalbumin (14 kDa); lane 2: supernatant after cell
lysis (supernatant 1); lane 3: supernatant after resolubilisation of
¢rst 15 000 rpm pellet with 2.5% SDS and dialysis in the presence
of SDS (supernatant 2); lane 4: same as lane 3 but dialysed in the
absence of SDS (supernatant 3). See Section 2 for details.
S. Zaltash, J. Johansson /FEBS Letters 423 (1998) 1^42
the maximum at about 195 nm further indicate a substantial
amount of K-helical structure. About 35% of helical content is
estimated from the molar ellipticities of rproSP-B at 208 and
222 nm. Recombinant proSP-B stored for 4 months or treated
with DTT (5 mM, 5.5 h at 37‡C) exhibited CD spectra similar
to those of the freshly prepared protein (not shown).
A monoclonal anti-human SP-B antibody (HS-2, [15]) re-
acted with rproSP-B, both in the absence and presence of
DTT, while no cross-reactivity was found with trypsin-di-
gested rproSP-B (data not shown).
SDS/PAGE of rproSP-B under non-reducing conditions
does not give detectable bands at about 43 kDa, but the
protein forms high molecular mass oligomers, which enter
the gel with di⁄culty. This oligomerisation was con¢rmed
by gel ¢ltration on Superose 12 in the absence of reducing
agents which did not show elution of any protein correspond-
ing to monomeric proSP-B. It is therefore concluded that
rproSP-B produced in E. coli consists of disulphide-dependent
oligomeric forms. Also after reduction and reoxidation,
rproSP-B is not monomeric.
3.3. Limited proteolysis of rproSP-B
CD spectroscopy of rproSP-B thus indicated a similar hel-
ical content as in SP-B. However, the helical contents esti-
mated for the two proteins may not be directly comparable
(see below). We therefore next wanted to ¢nd out whether the
proposed conformation of proSP-B, containing three saposin-
like domains, could be experimentally veri¢ed. If three sapo-
sin-like domains are present in rproSP-B, limited proteolysis,
which is known to cleave preferentially at exposed areas [16],
should give cleavages in the regions outside the saposin-like
domains more frequently than within the domains, since each
saposin-like domain is expected to be tightly folded due to the
presence of three intra-chain disulphide bridges. Signi¢cantly,
limited proteolysis of rproSP-B with trypsin produced 11 ma-
jor bands which were resolved by SDS/PAGE. These bands
were electrotransferred from the gel to PVDF membranes and
subjected to sequence analysis. The amino acid sequences,
determined for 6 to 19 cycles, in all but one case unambigu-
ously assigned the cleavage position (Fig. 3).
4. Discussion
ProSP-B fused to an N-terminal poly-His tag was expressed
in E. coli and puri¢ed from inclusion bodies by metal a⁄nity
chromatography after resolubilisation with 2.5% (w/v) SDS.
This yields approximately 1.5 mg rproSP-B/l cell culture.
ProSP-B has previously been expressed in CHO cells [17],
mammary gland of transgenic mice [18] and E. coli [19]. In
the latter case the protein expressed was puri¢ed and refolded
simultaneously by solubilisation with guanidinium-hydro-
chloride and subsequent removal of the denaturant after im-
mobilisation of the His-tagged protein on a metal a⁄nity
column [18]. With our experimental setup removal of SDS
prior to a⁄nity chromatography greatly increases the yield
of rproSP-B (Fig. 1). Thus, it can be concluded that SDS is
required for solubilisation of aggregated/denatured rproSP-B
and that the protein refolds into a conformation which is
soluble in aqueous bu¡er upon gradual removal of the dena-
turant. ProSP-B expressed in type II cells and in a pulmonary
adenocarcinoma cell line is apparently monomeric also in the
absence of reducing agents [20,21]. In contrast, proSP-B ex-
pressed in E. coli apparently forms higher order disulphide-
dependent oligomers. This is likely caused by the abundance
of Cys residues in proSP-B and inadvertent disulphide forma-
tion (25 Cys in human proSP-B, of which 6 are located out-
side the saposin-like domains). Further, it should be pointed
out that SP-B puri¢ed from alveolar surfactant and native
proSP-B also di¡er in quaternary structure. Thus, SP-B puri-
¢ed from alveolar surfactant exists mainly as a homodimer
[1,22], while native proSP-B is a monomer [20,21]. It remains
to be established whether the covalent dimerisation occurs at
the level of proSP-B or SP-B. Anyway, in spite of the di¡er-
ence in quaternary structure between recombinant and endog-
enous proSP-B, the secondary structure and domain organi-
sation of rproSP-B was now found to be as expected from
sequence alignments [8].
The CD spectrum of rproSP-B indicates that it contains
about 35% K-helix (Fig. 2). Di¡erent saposin-like proteins
have been found to contain between 26 and 53% helices, see
[9]. SP-B contains about 45% helices as determined by Fourier
transform infrared and CD spectroscopy [7,9]. The present
CD data are thus compatible with the idea [8] that rproSP-
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Fig. 3. Summary of results from proteolytic cleavage of rproSP-B
with trypsin. In the upper line the three tandem saposin-like do-
mains are boxed. The boxes cover the region from the ¢rst to the
last (sixth) Cys that forms intramolecular disulphides in each do-
main. Domain 1 covers residues 69^143, domain 2 residues 208^277
and domain 3 residues 299^375. Mature SP-B corresponds to do-
main 2. Each vertical bar indicates Arg or Lys in the amino acid se-
quence. The arrows show the identi¢ed trypsin cleavage sites. In the
lower line the sequence similarities between canine, rabbit, rat and
human proSP-B [3,26^28] are summarised. Each vertical bar repre-
sents a position of variability (de¢ned as di¡erent residues in two or
more of the sequences).
Fig. 2. Circular dichroism spectroscopy of recombinant proSP-B.
CD spectra of rproSP-B in 50 mM phosphate bu¡er, pH 8.0 (solid
line), and SP-B in 10 mM dodecylphosphocholine/50 mM phosphate
bu¡er, pH 6.0 (dashed line).
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B is composed of three saposin-like domains. It should how-
ever be pointed out that experimentally determined secondary
structure contents of di¡erent saposin proteins may not be
directly comparable for two reasons. First, proSP-B contains
signi¢cant regions located outside the saposin-like domains
(Fig. 3), the secondary structure of which of course in£uences
the CD spectrum of rproSP-B. Second, because of its hydro-
phobic nature, SP-B can only be studied in detergent micelles
or in the presence of organic solvents, while rproSP-B was
analysed in aqueous solution. However, for NK-lysin CD
spectra have been recorded both in aqueous solution and in
the presence of DPC micelles, and no signi¢cant di¡erences in
secondary structure could then be observed [9].
Limited proteolysis of rproSP-B indicates that the three
saposin-like domains are located as indicated in Fig. 3. A
clear correlation between sites of limited proteolysis and seg-
mental mobility has been documented for several proteins
[16]. Similarly, the limited proteolysis of proSP-B shows pref-
erential cleavage in those segments which are expected to ex-
hibit high £exibility if the polypeptide is folded into three
saposin-like domains. Eight of the ten cleavage sites identi¢ed
are located outside of the proposed saposin-like domains.
Although the remaining two cleavage sites were found within
the saposin-like domains, they are situated in the same region
in domains 1 and 2, where domain 2 corresponds to SP-B
(Fig. 3). This region is located between half-cystine residues
3 and 4 in the respective domains. These half-cystines form a
disulphide bridge in SP-B, and probably also in domain 1, and
the peptide bond where the two cleavages occur is expected to
be located in the last turn of a helix which precedes a loop
that lacks ordered structure [9]. Likewise, in the recently de-
termined NMR structure of NK-lysin, the position corre-
sponding to the bond now cleaved precedes the last residue
of helix 2 [23]. Taken together, the present CD and proteolysis
data lend experimental support to an arrangement of proSP-B
into three saposin-like domains.
Of the three saposin-like domains present in proSP-B, only
SP-B has been isolated. It is an open question whether the
remaining two saposin-like domains in proSP-B are processed
to yield unique entities or if the sole function of proSP-B is to
give rise to SP-B. Sequence alignments of canine, rabbit, rat
and human proSP-B show that the ¢rst and second (i.e. SP-B)
domains exhibit a high degree of conservation, while the third
domain is little conserved (Fig. 3). Notably, the proSP-B N-
terminal part, but not the C-terminal region, is required for its
processing and intracellular targeting [24,25]. The conserva-
tion of the ¢rst saposin-like domain may indicate that it is
particularly important for proSP-B functions, or that it serves
a role also after processing of proSP-B to SP-B.
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